Skip to main content

REGENXBIO Inc.

RGNX
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001590877

In the last 90 days, REGENXBIO Inc. insiders filed 1 open-market purchase and 2 sales; 165 institutions reported holding it in 13F filings for Q2 2026, worth $504.6M in total; no superinvestor holds it.

13F holders, Q2 2026

Institutional positions in REGENXBIO Inc. as of Jun 30, 2026. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
165
−11 vs. Q1 2026
Shares held
42.2M
−332.2K (−0.8%) vs. Q1 2026
Total value
$504.6M
+$150.1M (+42.3%) vs. Q1 2026
New holders
24
62 more added
Sold out
35
52 more reduced

2 institutions that held it in Q1 2026 haven't filed for Q2 2026 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.

Compare with Q1 2026: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting RGNX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ2 2026: 165 institutions
Q1 2021: 184 institutionsQ2 2021: 172 institutionsQ3 2021: 183 institutionsQ4 2021: 172 institutionsQ1 2022: 187 institutionsQ2 2022: 166 institutionsQ3 2022: 183 institutionsQ4 2022: 182 institutionsQ1 2023: 175 institutionsQ2 2023: 167 institutionsQ3 2023: 160 institutionsQ4 2023: 171 institutionsQ1 2024: 188 institutionsQ2 2024: 181 institutionsQ3 2024: 186 institutionsQ4 2024: 177 institutionsQ1 2025: 164 institutionsQ2 2025: 159 institutionsQ3 2025: 166 institutionsQ4 2025: 174 institutionsQ1 2026: 178 institutionsQ2 2026: 165 institutions
Value heldQ2 2026: $504.6M
Q1 2021: $1.12BQ2 2021: $1.30BQ3 2021: $1.40BQ4 2021: $1.16BQ1 2022: $1.16BQ2 2022: $895.7MQ3 2022: $926.6MQ4 2022: $808.9MQ1 2023: $700.0MQ2 2023: $742.1MQ3 2023: $610.3MQ4 2023: $684.3MQ1 2024: $896.6MQ2 2024: $511.9MQ3 2024: $458.1MQ4 2024: $325.2MQ1 2025: $298.0MQ2 2025: $344.9MQ3 2025: $399.2MQ4 2025: $593.1MQ1 2026: $355.1MQ2 2026: $504.6M
Institutions holding RGNX and their total value by quarter
QuarterHoldersValue
Q2 2026165$504.6M
Q1 2026178$355.1M
Q4 2025174$593.1M
Q3 2025166$399.2M
Q2 2025159$344.9M
Q1 2025164$298.0M
Q4 2024177$325.2M
Q3 2024186$458.1M
Q2 2024181$511.9M
Q1 2024188$896.6M
Q4 2023171$684.3M
Q3 2023160$610.3M
Q2 2023167$742.1M
Q1 2023175$700.0M
Q4 2022182$808.9M
Q3 2022183$926.6M
Q2 2022166$895.7M
Q1 2022187$1.16B
Q4 2021172$1.16B
Q3 2021183$1.40B
Q2 2021172$1.30B
Q1 2021184$1.12B

Institutions, Q2 2026

Shares, value and share of portfolio for each institution holding REGENXBIO Inc.; share changes are against Q1 2026.

Institutions holding RGNX in Q2 2026
InstitutionSharesValue% of portfolioChange in sharesAction
CWM, LLC––––Not filed
Sunbelt Securities, Inc.––––Not filed